Intuitive Surgical Executives Sell $145 Million in Company Stock

On January 27, Gary S. Guthart, Chairman of the Board of Intuitive Surgical, Inc. (NASDAQ: ISRG), exercised stock options to acquire shares and, under a pre-established Rule 10b5-1 trading plan, sold approximately $14.5 million (KRW 20 billion) of company stock, including shares held in his own and his children’s trusts. On the same day, Chief Medical Officer Myriam Curet also exercised a small number of options and sold all resulting shares on the open market. Both executives continue to hold a significant stake in the company’s stock and related trusts following these transactions.

In its fourth-quarter 2025 earnings report released on January 22, the company announced revenue of $2.87 billion, up 19% year over year, driven by increased procedure volume using its da Vinci and Ion systems. For 2026, Intuitive expects to sustain growth, forecasting a 13–15% increase in da Vinci procedures and aiming to maintain a non-GAAP gross margin of 67–68%.

Headquartered in Sunnyvale, California, Intuitive Surgical is a global leader in robotic surgical systems, supplying its minimally invasive da Vinci surgical system series and its Ion system for lung biopsies to hospitals worldwide. Since its founding in 1995, the company has secured a near-monopoly in the robotic surgery market, and as of 2025 generated annual revenues of approximately $10 billion (about KRW 13 trillion).